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ABSTRACT
Background    The aim of this paper was to evaluate 
the validity of tumor volume measurement using diffu-
sion-weighted (DW) imaging in cervical cancer.
Methods    In this retrospective study, 22 patients, who 
underwent preoperative 3.0 T MR examinations with 
DW imaging were evaluated. Tumor volume measure-
ment by oblique axial (short axis to the uterine cervix) 
T2-weighted imaging was performed by manually out-
lining the tumor on the monitor. The area of tumor in 
each slice was multiplied by the slice profile (slice thick-
ness plus intersection gap), and the total tumor volume 
was calculated by summation of these obtained volumes. 
Meanwhile, one experienced radiological technologist 
generated three-dimensional DW images of cervical 
cancer using a volume-rendering algorithm at a com-
puter workstation, and tumor volume was automatically 
calculated in the workstation. Analysis via the intraclass 
correlation coefficient (ICC) and Bland-Altman plots 
were used to assess the validity and reliability of these 
methods.
Results     Between tumor volumes measured by 
T2-weighted imaging methods and DW imaging meth-
ods, the ICC was excellent (0.962). The 95% limits of 
agreement of volume measurement were –52.7 and 35.7 
mL (mean difference, –8.5 mL). In regards to intra-ob-
server variability, the ICC was excellent (0.963). The 
95% limits of agreement of volume measurement were 
–42.2 and 47.4 mL (mean difference, 2.6 mL).
Conclusion    DW imaging can be used to measure cer-
vical cancer volume. 
Key words    Diffusion magnetic resonance imaging; 
magnetic resonance imaging; three-dimensional imag-
ing; uterine cervical neoplasms; volume measurement 
Magnetic resonance (MR) imaging can estimate the 
size and extension of primary tumors more accurately 
than was previously possible by clinical palpation.1–3 
Although International Federation of Gynecology and 
Obstetrics (FIGO) has not necessarily endorsed clinical 
staging of patients with cervical carcinoma based on ad-
ditional information gained by MR imaging, the modali-
ty has been described as the most accurate, non-invasive 
imaging modality for staging of cervical carcinoma.3–6 
Moreover, tumor size and volume assessed by MR im-
aging significantly correlates with outcome for patients 
with uterine cervical cancer.7–10 
 Diffusion-weighted (DW) imaging has been wide-
ly used for the detection and characterization of focal 
lesions.10–17 Several recent reports have demonstrated 
that direct visual assessment of DW images facilitates 
detection of malignant lesions because it provides excel-
lent tissue contrast.11, 12, 14, 18, 19 Other reports suggest that 
DW imaging is useful for measurement of the volume 
of acute cerebral infarction20, 21 and tumors by delineat-
ing the tumor in cross-sectional images.22, 23 Kwee et al. 
reported that volume-rendered DW imaging shows the 
three-dimensional (3D) shape of the tumor and allows 
for tumor volume measurement.17 However, the measure-
ment has not been fully evaluated. Therefore, the goal 
of the present study was to investigate the utility of DW 
imaging for volume measurement of cervical cancer.
MATERIALS AND METHODS 
Patient Population
Forty-three consecutive female patients who underwent 
preoperative MR examinations with a 3.0 T MR system 
between October 2006 and November 2008 and who 
had pathological confirmation of cervical cancer at our 
institution were included in this retrospective study. Of 
these patients, 20 patients with stage Ia or Ib1 disease 
were excluded, because the tumors were not advanced 
cancers. One patient with a large tumor was excluded 
because the entire tumor could not be delineated on DW 
imaging. 
 Therefore, 22 patients (age range, 33–82 years; 
mean age, 53 years), who underwent preoperative MR 
examinations including DW imaging on a 3.0 T MR sys-
tem were enrolled in the present study. The Institutional 
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Review Board approved this study, which did not require 
informed consent (#1665). FIGO stage was Ib2 in six 
patients, IIa in two patients, IIb in seven patients, IIIb in 
two patients, IVa in one patient, and IVb in four patients. 
MR Technique
MR imaging was performed with a 3.0 T MR system 
(Signa EXCITE HD; GE Medical Systems, Milwaukee, 
WI) with eight-channel cardiac coils. A dielectric pad 
was placed on the patient’s body in order to improve the 
image homogeneity. After acquisition of localization 
images, T2-weighted fast spin-echo images were ob-
tained in parasagittal planes parallel to the longitudinal 
axis of the uterus and in oblique axial planes taken in a 
direction parallel to the short axis of the uterine cervix. 
T1-weighted gradient-echo images were also obtained 
in parasagittal planes parallel to the longitudinal axis of 
the uterus and in axial planes of the body. The imaging 
parameters of T2-weighted images were as follows: rep-
etition time ms/echo time ms, 6500/100 for parasagittal 
planes and oblique axial planes (short axis to the uterine 
cervix). The matrix size was 512 × 384, and the section 
thickness was 5 mm in the parasagittal planes and 2-4 
mm in the oblique axial planes. The intersection gap 
was 1.5 mm in the parasagittal planes and 0.2-1.5 mm 
in the oblique axial planes, with a 25-cm field of view 
(FOV). 
 Axial DW images were then obtained. Imaging pa-
rameters for DW imaging were as follows: TR/TE/inver-
sion time (TI), 5000-5675/59.3/200 ms; b factors, 0 and 
1000 s/mm2; 128 × 128 matrix; 400 mm FOV; section 
thickness, 4 mm with no gap; SENSE reduction factor, 
2; two signals acquired; acquisition time, approximately 
3.5 minutes. A DW imaging sequence was used for fat 
suppression in a short-inversion -time inversion recovery 
(STIR)-echo planar imaging sequence, with free breath-
ing during acquisition. Motion-probing gradient pulses 
were placed in three orthogonal planes. Isotropic DW 
imaging was generated using three orthogonal-axis im-
ages. 
 Before examination, all patients received intramus-
cular administration of 20 mg of butyl-scopolamine 
(Buscopan; Nippon Boehringer Ingelheim, Tokyo, Ja-
pan) to prevent peristalsis artifacts, except when contra-
indicated.
Tumor volume measurement by T2-weighted im-
aging
Tumor volume measurement by T2-weighted imaging 
was performed by one radiologist who had 12 years of 
experience in gynecological MR imaging. In oblique ax-
ial plane images, the tumor mass was manually outlined 
Fig. 1. MR images in a 57-year-old woman with cervical cancer.
a) Sagittal T2-weighted image. b) oblique axial (short axis to the 
uterine cervix) T2-weighted image. T2 weighted images show the 
cervical tumor invading to the uterine body and vagina (a, b). The 
boundary of the tumor is drawn manually by the radiologist on 




on the monitor (EV Insite; PSP Corporation, Tokyo, Ja-
pan) (Fig. 1). The area of tumor in each slice was multi-
plied by the slice profile (slice thickness plus intersection 
gap), and total tumor volume was calculated by sum-
mation of these obtained volumes. We used the volume 
obtained by T2-weighted imaging as a gold standard.
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Fig. 2. The tumor is displayed as a volume rendering image with 
axial and the multi-planar reconstructed coronal, sagittal images 
on the computer workstation (the same patient as in Fig. 1).
Fig. 4. Intra-observer variability of the tumor volume measure-
ment by diffusion-weighted imaging. Bland-Altman plots of the 
tumor volume measurement by diffusion-weighted images for two 
measurements by the reviewer. Bland-Altman plots show agree-
ment between two analyses of the volume measurements by the 
reviewer using diffusion-weighted images. The solid line in the 
graph represents the mean of the differences. The dotted line in 
the graph represents the corresponding 95% limits of agreement. 
Observations within 95% limits of agreement likely result from 
measurement error; observations outside 95% limits of agreement 
likely result from true differences between both methods. 
Fig. 3. Comparison of the tumor volume measurement by 
T2-weighted imaging and diffusion-weighted imaging. Bland-Al-
tman plots between the tumor volume measurements by 
T2-weighted images versus diffusion-weighted images. The solid 
line in the graph represents the mean of the differences. The dot-
ted line in the graph represents the corresponding 95% limits of 
agreement. Observations within 95% limits of agreement likely 
result from measurement error; observations outside 95% limits of 
agreement likely result from true differences between both meth-
ods. 
Tumor volume measurement by DW imaging
One radiological technologist who was experienced in 
the workstation generated 3D shaped DW images of cer-
vical cancer using a volume-rendering (VR) algorithm 
at a commercially available computer workstation (AZE 
Virtual Place; Office Azemoto Ltd., Tokyo, Japan). Axi-
al DW images were loaded, and the multi-planar recon-
structed coronal, sagittal and VR images were displayed 
in an appropriate window setting. Cervical cancer was 
decided as uterine abnormal strong signal intensity 
except for normal endometrium on VR images while 
referring to the axial and multi-planar reconstructed 
coronal and sagittal images. The software automatical-
ly segmented the lesion from the surrounding adjacent 
structures, such as the intestine, using an object recog-
nition algorithm. The boundary of the segmented lesion 
was then displayed on the monitor (Fig. 2). The technol-
ogist and radiologist visually assessed if the automated 
algorithm accurately segmented the lesion, excluding 
adjacent structures, such as the intestine, rectum and en-
dometrium. If needed, the technologist manually adjust-
ed the boundary of the tumor, determining the boundary 
between the lesion and adjacent structures by visual 
assessment. After segmentation and manual correction, 
the volume of the tumor was automatically calculated in 
the workstation. The time needed for volume measure-
ment was generally a few minutes. Tumor volume mea-
surement was repeated at more than 6 months from first 
analysis by the same technologist.
Statistical analysis
The intraclass correlation coefficient (ICC) was used to 
assess the agreement of measurements when evaluat-
ing the relationship between tumor volumes measured 
according to the T2-weighted imaging method and 
those measured according to the DW imaging method. 
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Bland-Altman plots were used to characterize the limits 
of agreement. Intra-observer variability was also as-
sessed by ICC and by Bland-Altman plots.
 Data were analyzed by using statistical software 
(MedCalc; MedCalc Software, Mariakerke, Belgium).
RESULTS
The tumor volume by T2-weighted images ranged from 
3.77 to 249.75mL (mean 79.01 mL), while the volume by 
DW images ranged from 9.81 to 285.43 mL (mean 87.52 
mL). 
 The ICC was excellent (0.962) when comparing tu-
mor volumes measured by T2-weighted imaging meth-
ods and those measured by DW imaging methods. The 
95% limits of agreement of volume measurement were 
–52.7 and 35.7 mL (mean difference,  –8.5 mL) (Fig. 3).
 Regarding intra-observer variability, ICC was ex-
cellent (0.963). The 95% limits of agreement of volume 
measurement were –42.2 and 47.4 mL (mean difference, 
2.6 mL) (Fig. 4).
DISCUSSION
For imaging-based tumor volume assessment, the vol-
umes of cervical cancer have traditionally been estimat-
ed from measurements of the three diameters of the tu-
mor.2, 7, 9 Specifically, the longitudinal diameter (d1), the 
anteroposterior diameter (d2) and the lateral diameter (d3) 
are measured, and the diameter-based tumor volume is 
then calculated from the diameters as an ellipsoid (vol-
ume = d1 × d2 × d3 × π/6). More properly, some studies 
have reported that the tumor volume was calculated as 
the 3D volume by summation of the tumor area from 
all slices and by multiplying by image thickness plus 
image gap, which was a good predictor of tumor control 
or survival.24–26 Such ROI-based quantitative volume 
measurement is more troublesome and time-consuming 
than the diameter-based measurement, making its prac-
tical application in a busy clinical setting challenging. 
However, technological advancements have resulted in 
this method becoming more readily available and more 
user-friendly for use in general practice.27 Some recent 
reports describe tumor volume measurement using a 3D 
workstation.28, 29 However, the validation of volume mea-
surement using DW imaging on a 3D workstation has 
not been fully investigated.
 The present study demonstrated that tumor volume 
could be assessed using DW imaging. Several reports 
have demonstrated that direct visual assessment of DW 
images facilitates detection of malignant lesions, because 
DW imaging provides excellent tissue contrast.11,12, 14, 18, 19 
In gynecological imaging, DW imaging can be helpful for 
the detection of peritoneal dissemination and uterine endo-
metrial cancer.12, 13, 16 Cervical cancer tumors generally 
show strong signal intensity on DW images, reflecting 
a decrease in apparent diffusion coefficient (ADC) val-
ues.30 Therefore, the success of volume assessment in 
the present study is due to the ability of DW imaging to 
provide excellent tissue contrast, thereby clearly discrim-
inating the strong signal intensity of cervical cancers. 
DW imaging can obtain total volume measurements as 
another potential application of its imaging, as was de-
scribed in a previous review article.17 
 However, the tumor volume was slightly larger 
when assessed by DW imaging than when assessed 
by T2-weighted imaging, although ICC was excellent 
between two volumes. This may be mainly related to 
partial volume effects due to the larger voxel size and 
decreased information about the anatomy of the sur-
rounding structures. Additionally, the susceptibility ar-
tifact from air of the rectal cavity may affect the results. 
We evaluated the DW images not in a fixed window but 
in an appropriate setting, because signal intensity on MR 
imaging is not an absolute value; the window setting 
can influence the tumor area and thereby affect volume 
measurement. Therefore, methods to determine the ap-
propriate window setting still need to be established.
 Some reports have demonstrated that the ADC can 
be used to predict and monitor the response of uterine 
cervical cancer to therapy.31, 32 The ADC value is useful 
for detection of pelvic lymph node metastasis in patients 
with cervical cancers.33 We demonstrated that DW im-
aging could obtain total volume measurements of cervi-
cal cancer. Therefore, volume measurement using DW 
imaging may be useful for the therapeutic management 
of cervical cancer, because tumor volume significantly 
correlates with outcome in patients with uterine cervical 
cancer.7–10 Thus, DW imaging may play a role in various 
aspects of cervical cancer, including its diagnosis, as-
sessment of the response to therapy, and for determina-
tion of prognosis.
 This study has some limitations. First, the study 
population was small, and further studies are required in 
a larger population. Second, the review was performed 
by one observer, because technologists who were fa-
miliar with this 3D workstation were not available in 
our institution; therefore, we do not show inter-observer 
variability data, and this subject needs to be evaluated in 
future studies. Third, we did not assess the time needed 
for volume measurement on DW imaging systematically 
in comparison to the time using T2-weighted imaging, 
although we consider that the measurement using DW 
imaging is probably less time consuming. Lastly, we did 
not assesse the relationships between the volume on DW 
imaging and the prognosis. The evaluation would be 
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needed to utilize the measurement method.
 In conclusion, volume measurement using DW im-
aging can be used to measure tumor volume in patients 
with cervical cancer. DW imaging may play a role in 
various aspects of cervical cancer, including its diagno-
sis, assessment of the response to therapy, and for deter-
mination of prognosis.
The authors declare no conflict of interest.
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